How CSF Flows at the Brain-Meninges Border Shapes Brain Health and Disease

The brain has long been considered immunologically privileged, yet recent discoveries have overturned this view by revealing dynamic fluid and immune exchange at the brain–meningeal border. This comprehensive review in The Lancet Neurology synthesizes groundbreaking research on the structural and functional organization of cerebrospinal fluid (CSF) transport across the glymphatic system, meningeal lymphatics, and newly described arachnoid cuff exit points, examining their roles in neurological health and disease.

The glymphatic system, a network of perivascular channels lined by astrocytic aquaporin-4 (AQP4) water channels, facilitates bulk flow of CSF through the brain parenchyma, enabling clearance of metabolic waste products including amyloid-beta and tau proteins. The review details how CSF entering via periarterial spaces traverses the brain interstitium and exits via perivenous routes, ultimately draining into the meningeal lymphatic vessels of the dural layer. These meningeal lymphatics serve as conduits connecting the CNS to peripheral cervical lymph nodes, enabling immune surveillance and antigen drainage from the brain.

A particularly novel contribution highlighted in the review is the characterization of arachnoid cuff exit points—specialized structures at cranial nerve and blood vessel exit sites through the dura—through which CSF, solutes, and immune cells can transit between the subarachnoid space and the skull bone marrow. This skull bone marrow has emerged as a reservoir of CNS-patrolling myeloid cells that access the meninges through microscopic channels in the calvaria, creating a previously unrecognized axis of neuroimmune communication.

Pathological implications are extensive. In Alzheimer's disease, meningeal lymphatic dysfunction and reduced glymphatic clearance correlate with amyloid accumulation and cognitive decline, and these deficits worsen with aging. Traumatic brain injury triggers acute inflammatory cascades at the meningeal border that compromise lymphatic and glymphatic integrity. In multiple sclerosis, aberrant meningeal immune aggregates form near compromised lymphatic vessels and may sustain chronic neuroinflammation. Brain tumors exploit meningeal and perivascular routes for immune evasion and metastasis. Viral and bacterial CNS infections also alter CSF transport dynamics, influencing pathogen dissemination and immune response.

Therapeutically, interventions targeting meningeal lymphatic function—such as vascular endothelial growth factor C (VEGF-C) delivery, sleep optimization (which enhances glymphatic clearance), and physical exercise—show promise in preclinical models. Human imaging studies have begun to validate glymphatic and lymphatic metrics as biomarkers of brain health. The review acknowledges that translating rodent findings to human physiology remains challenging due to anatomical and scale differences, and that many mechanistic studies rely on invasive or acute experimental paradigms that may not capture chronic disease dynamics.